COVID-19 Response for RECALL Study
Due to the current COVID-19 situation, we have been advised to suspend all face to face study activity to ensure patient safety. As some of our RECALL Study processes are carried out online, you can continue to register, provide information to the study webpages and complete the study online games, should you wish. We will continue to adhere to the Government and NHS guidance and will contact you at a future date to complete the RECALL Study visits when it is safe to do so.
If you want to discuss any aspects of the RECALL Study or your participation, please contact us via the RECALL Study website or email recall@dundee.ac.uk. Please note, our staff are now working remotely, and some are involved in frontline care so it may take us a little longer than usual to reply.
We value your understanding and cooperation during this time. Your contribution to the study is greatly appreciated.
What is the RECALL study?
You may have received a letter from your GP informing you about this study.
The RECALLpilot study was designed to determine the feasibility of a prospective, randomised, double-blind clinical trial of reducing systolic blood pressure to prevent dementia and cognitive decline.
Dementia is one of the biggest health and social care challenges of the 21st century. Unfortunately, there is no cure for the most common types of dementia. However, latest research suggests we can protect our brains by controlling our blood pressure, and there is growing evidence that dementia can be prevented in this way.
We plan to conduct a large online study to test whether giving people medication to lower blood pressure reduces their risk of developing dementia. Before we do this, we want to check that the various parts of the study will work when used by participants and healthcare professionals in the real world. This RECALL pilot study aims to test whether the final study will work, or if we need to make changes to ensure that taking part is straightforward. There are two parts to the pilot study:
Part one involves registering for the study, providing consent, and entering personal and medical details into a secure personal account via this website. You will also be asked to complete some cognitive (brain) function games to assess your thinking and memory.
Part two involves visiting your GP practice, or MEMO Research at Ninewells Hospital, for a blood test. We will also give you a blood pressure monitor so that you can measure your blood pressure at home and enter the results into your account via the study website.
A short video summarising this pilot study is also available to view by clicking below.
You may view the Patient Information Sheet that details all aspects of the study by clicking here. View Patient Information Sheet.
If you would like to know more about the RECALL pilot study, please fill in the Contact Us form below, or call the RECALL team on 0800 9173509.
Your help with this study would be very much appreciated. If you wish to join the RECALL pilot study, please click below to register:
Frequently Asked Questions
I am going on holiday next week. Can I still take part?
I don’t have a computer. Can I still take part?
Need to get in touch?
By Post
RECALL study,
MEMO Research, Level 7,
Ninewells Hospital and Medical School,
Dundee, UK,
DD2 1GZ
By Phone
01382 383119
Monday to Friday
8.45am to 5.00pm
Resources
For more detailed information about dementia and high blood pressure, please click the links below. On these pages, you will find additional information and links to other peer reviewed papers covering this research area.
The Team
Here to help you
Dr Evelien Rooke
Clinical Reseach Fellow and Senior Neurology Registrar Doctor. Particular interests include neurocognitive disorders and medical education.
Dr Greg Guthrie
Clinical Research Fellow and Specialty Trainee in Nephrology and General Medicine. Interests in chronic kidney disease, inequality and rational study design.
Dr Amy Rogers
Clinical Research Fellow focusing on large scale drug safety and effectiveness trials. Particular interests include pragmatic research methodologies and evidence based prescribing in primary care.
Caroline Hall
Lead Clinical Trials Nurse with extensive clinical research experience in large, randomised, long-term multi-centre studies. Particular interests include trial recruitment and retention and improving participant’s experience of trials.
Kris Zutis
Lead RECALL study developer at MEMO Research. Main research interests include enhancing digital clinical trials as well as the application of machine learning techniques for advancing medical research.
Lewis McConnachie
IT manager for MEMO Research. Focusing on improving clinical technlogy in healthcare for the public and medical professionals.
